Bayer Looks to Develop More Weed-Killers as Roundup Litigation Continues
June 14 2019 - 03:02AM
Dow Jones News
By Cristina Roca
Bayer AG (BAYN.XE) plans to invest about 5 billion euros ($5.64
billion) over the next decade to develop more methods for fighting
weeds, as it continues to face litigation over the glyphosate-based
weed-killer Roundup.
"While glyphosate will continue to play an important role in
agriculture and in Bayer's portfolio, the company is committed to
offering more choices for growers," the German pharmaceuticals and
chemicals company said Friday.
Bayer inherited Roundup after acquiring seed-and-pesticide group
Monsanto in 2018, and now faces thousands of legal claims
connecting the herbicide to cancer.
The company on Friday also promised that its agricultural
solutions will reduce environmental impact 30% by 2030 by
developing new technologies, reducing crop-protection volumes and
allowing for more precise application, it said.
These measures address "concerns Bayer has heard about its role
in agriculture in the year following its acquisition of Monsanto,"
the company said.
Bayer said it will invite scientists, journalists and NGO
representatives to participate in scientific preparation as it gets
ready to re-register its glyphosate herbicide in the European
Union.
Write to Cristina Roca at cristina.roca@dowjones.com;
@_cristinaroca
(END) Dow Jones Newswires
June 14, 2019 02:47 ET (06:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2023 to Mar 2024